Two production blocks of Phase 1 are expected to be fully operational by the end of calendar year 2025
Aether Industries Limited, India’s leading specialty chemicals manufacturer, reported Q1 FY26 revenue of Rs. 259 crore, an increase of 35% YoY whereas PAT reached Rs. 47 crore, up by 57% YoY.
EBITDA for the quarter stood at Rs. 78 crore (EBITDA margin 30%), representing a year-on-year growth of 94%. These results underscore Aether’s strategic execution, robust market positioning, and continued push towards value-added segments.
The company continued to deepen its focus on Contract/Exclusive Manufacturing (CEM) and Contract Research and Manufacturing Services (CRAMS) as key revenue drivers. Improved cost management and production efficiency further contributed to a PAT (Profit After Tax) of Rs. 47 crore (PAT Margin 18%), up 57% from Q1 of FY25.
In terms of revenue mix of the Business Models, for the quarter, CEM contributed 37%, CRAMS contributed 10%, and the remaining was contributed by Large-Scale Manufacturing, showcasing a well-balanced and resilient business model.
The specialty chemicals manufacturer has commenced construction of a new manufacturing unit (Site-5) at Panoli GIDC on Surat-Ahmedabad highway. Two production blocks of Phase 1 are expected to be fully operational by the end of calendar year 2025. An adjacent land parcel has also been acquired, increasing the total project area to 46 acres, further strengthening the company's infrastructure and expansion roadmap.
The quarter also witnessed significant strategic developments. In June 2025, Aether entered into a 10 years Contract Manufacturing Agreement with Milliken Chemical and Textile (India) Co. Private Limited, a wholly owned subsidiary of USA headquartered Milliken & Company (Milliken).
This contract is designed to expand Aether’s manufacturing utilization and ensure stable long-term revenue, while highlighting its world-class R&D and manufacturing capabilities.
Following this agreement, Aether began expansion activities at Site-3+. Equipment procurement is currently underway and all necessary regulatory approvals have been secured. Production under the CEM model for Milliken’s strategic products is expected to commence by the end of this financial year.
Commenting on the results, Rohan Desai, Co-Founder & Director of commercial at Aether Industries said, “The Q1 of FY26 performance is a reflection of our innovation-led growth, commitment to sustainability and a vision to build a globally recognized brand. Strategic partnerships with global giants such as Milliken continue to pave the way for a strong and bright future for Aether Industries.”
Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport
Subscribe To Our Newsletter & Stay Updated